Best Practice & Research Clinical Anaesthesiology
Volume 23, Issue 4 , Pages 375-386 , December 2009

Hyperglycaemia as part of the stress response: the underlying mechanisms

  • S.J. Van Cromphaut, MD (Professor of Medicine)

      Affiliations

    • Corresponding Author InformationTel.: +32 16 344021; Fax: +32 16 344015.

References 

  1. Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance. Journal of Clinical Investigation. 2000;106:165–169
  2. Bone RC, Sprung CL, Sibbald WJ. Definitions for sepsis and organ failure. Critical Care Medicine. 1992;20:724–726
  3. Cerra FB. Hypermetabolism, organ failure, and metabolic support. Surgery. 1987;101:1–14
  4. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. New England Journal of Medicine. 2001;345:1359–1367
  5. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. New England Journal of Medicine. 2006;354:449–461
  6. Vlasselaers D, Milants I, Desmet L, et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet. 2009;373:547–556
  7. Van den Berghe G, Schetz M, Vlasselaers D, et al. Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target?. Journal of Clinical Endocrinology & Metabolism. 2009;94:3163–3170
  8. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine. 2009;360:1283–1297
  9. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine. 2008;358:125–139
  10. Baron AD, Brechtel G, Wallace P, et al. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. American Journal of Physiology. 1988;255:E769–E774
  11. Shepherd PR, Kahn BB. Glucose transporters and insulin action–implications for insulin resistance and diabetes mellitus. New England Journal of Medicine. 1999;341:248–257
  12. Pessin JE, Bell GI. Mammalian facilitative glucose transporter family: structure and molecular regulation. Annual Review of Physiology. 1992;54:911–930
  13. Wolfe RR. Sepsis as a modulator of adaptation to low and high carbohydrate and low and high fat intakes. European Journal of Clinical Nutrition. 1999;53(Suppl. 1):S136–S142
  14. Stumvoll M, Chintalapudi U, Perriello G, et al. Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine. Journal of Clinical Investigation. 1995;96:2528–2533
  15. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Practice and Research Clinical Endocrinology and Metabolism. 2001;15:533–551
  16. Shulman RG, Bloch G, Rothman DL. In vivo regulation of muscle glycogen synthase and the control of glycogen synthesis. Proceedings of the National Academic Science USA. 1995;92:8535–8542
  17. Gerich JE. Control of glycaemia. Baillière's Clinical Endocrinology and Metabolism. 1993;7:551–586
  18. Stumvoll M, Meyer C, Mitrakou A, et al. Renal glucose production and utilization: new aspects in humans. Diabetologia. 1997;40:749–757
  19. Niijima A. Neural mechanisms in the control of blood glucose concentration. The Journal of Nutrition. 1989;119:833–840
  20. Iynedjian PB. Molecular physiology of mammalian glucokinase. Cellular and Molecular Life Sciences. 2009;66:27–42
  21. Moore MC, Connolly CC, Cherrington AD. Autoregulation of hepatic glucose production. European Journal of Endocrinology. 1998;138:240–248
  22. Tappy L, Chiolero R, Berger M. Autoregulation of glucose production in health and disease. Current Opinion in Clinical Nutrition and Metabolic Care. 1999;2:161–164
  23. Rossetti L, Giaccari A, Barzilai N, et al. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. The Journal of Clinical Investigation. 1993;92:1126–1134
  24. Hue L. The role of futile cycles in the regulation of carbohydrate metabolism in the liver. Advances in Enzymology and Related Areas of Molecular Biology. 1981;52:247–331
  25. Tappy L, Cayeux MC, Schneiter P, et al. Effects of lactate on glucose metabolism in healthy subjects and in severely injured hyperglycemic patients. American Journal of Physiology. 1995;268:E630–E635
  26. Shulman GI, Lacy WW, Liljenquist JE, et al. Effect of glucose, independent of changes in insulin and glucagon secretion, on alanine metabolism in the conscious dog. Journal of Clinical Investigation. 1980;65:496–505
  27. Frayn KN, Little RA, Maycock PF, et al. The relationship of plasma catecholamines to acute metabolic and hormonal responses to injury in man. Circulation Shock. 1985;16:229–240
  28. Barton RN. Neuroendocrine mobilization of body fuels after injury. British Medical Bulletin. 1985;41:218–225
  29. Frayn KN. Hormonal control of metabolism in trauma and sepsis. Clinical Endocrinology (Oxford). 1986;24:577–599
  30. Preissig CM, Rigby MR. Hyperglycaemia results from beta-cell dysfunction in critically ill children with respiratory and cardiovascular failure: a prospective observational study. Critical Care. 2009;13:R27
  31. Siegel JH, Cerra FB, Coleman B, et al. Physiological and metabolic correlations in human sepsis. Invited commentary. Surgery. 1979;86:163–193
  32. Miyoshi H, Shulman GI, Peters EJ, et al. Hormonal control of substrate cycling in humans. Journal of Clinical Investigation. 1988;81:1545–1555
  33. Wolfe RR. Substrate utilization/insulin resistance in sepsis/trauma. Baillière's Clinical Endocrinology and Metabolism. 1997;11:645–657
  34. Lang CH, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology. 1992;130:43–52
  35. Petit F, Bagby GJ, Lang CH. Tumor necrosis factor mediates zymosan-induced increase in glucose flux and insulin resistance. American Journal of Physiology. 1995;268:E219–E228
  36. Flores EA, Istfan N, Pomposelli JJ, et al. Effect of interleukin-1 and tumor necrosis factor/cachectin on glucose turnover in the rat. Metabolism. 1990;39:738–743
  37. Sakurai Y, Zhang XJ, Wolfe RR. TNF directly stimulates glucose uptake and leucine oxidation and inhibits FFA flux in conscious dogs. American Journal of Physiology. 1996;270:E864–E872
  38. Koivisto VA, Pelkonen R, Cantell K. Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes. 1989;38:641–647
  39. Lang CH, Molina PE, Yousef KA, et al. Role of IL-1 alpha in central nervous system immunomodulation of glucoregulation. Brain Research. 1993;624:53–60
  40. Petit F, Jarrous A, Dickinson RD, et al. Contribution of central and peripheral adrenergic stimulation to IL-1 alpha-mediated glucoregulation. American Journal of Physiology. 1994;267:E49–E56
  41. Mehta VK, Hao W, Brooks-Worrell BM, et al. Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. European Journal of Endocrinology. 1994;130:208–214
  42. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New England Journal of Medicine. 1995;332:1351–1362
  43. Hager P, Permert J, Wikstrom AC, et al. Preoperative glucocorticoid administration attenuates the systemic stress response and hyperglycemia after surgical trauma in the rat. Metabolism. 2009;58:449–455
  44. Wolfe RR, Durkot MJ, Allsop JR, et al. Glucose metabolism in severely burned patients. Metabolism. 1979;28:1031–1039
  45. Thorell A, Rooyackers O, Myrenfors P, et al. Intensive insulin treatment in critically ill trauma patients normalizes glucose by reducing endogenous glucose production. Journal of Clinical Endocrinology & Metabolism. 2004;89:5382–5386
  46. Kellum JA, Kramer DJ, Lee K, et al. Release of lactate by the lung in acute lung injury. Chest. 1997;111:1301–1305
  47. Curtis SE, Cain SM. Regional and systemic oxygen delivery/uptake relations and lactate flux in hyperdynamic, endotoxin-treated dogs. American Review of Respiratory Disease. 1992;145:348–354
  48. Haji-Michael PG, Ladriere L, Sener A, et al. Leukocyte glycolysis and lactate output in animal sepsis and ex vivo human blood. Metabolism. 1999;48:779–785
  49. Wilmore DW, Goodwin CW, Aulick LH, et al. Effect of injury and infection on visceral metabolism and circulation. Annals of Surgery. 1980;192:491–504
  50. Felig P, Pozefsky T, Marliss E, et al. Alanine: key role in gluconeogenesis. Science. 1970;167:1003–1004
  51. Roh MS, Moldawer LL, Ekman LG, et al. Stimulatory effect of interleukin-1 upon hepatic metabolism. Metabolism. 1986;35:419–424
  52. Wolfe RR. Carbohydrate metabolism in the critically ill patient. Implications for nutritional support. Critical Care Clinics. 1987;3:11–24
  53. McGuinness OP, Fugiwara T, Murrell S, et al. Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog. American Journal of Physiology. 1993;265:E314–E322
  54. Stumvoll M, Perriello G, Meyer C, et al. Role of glutamine in human carbohydrate metabolism in kidney and other tissues. Kidney International. 1999;55:778–792
  55. Shangraw RE, Jahoor F, Miyoshi H, et al. Differentiation between septic and postburn insulin resistance. Metabolism. 1989;38:983–989
  56. Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Medicine. 2004;30:748–756
  57. Aljada A, Ghanim H, Assian E, et al. Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism. 2002;51:487–491
  58. Nunes AL, Carvalheira JB, Carvalho CR, et al. Tissue-specific regulation of early steps in insulin action in septic rats. Life Sciences. 2001;69:2103–2112
  59. Gao Z, Hwang D, Bataille F, et al. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. The Journal of Biologicl Chemistry. 2002;277:48115–48121
  60. Barnes PJ, Karin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. New England Journal of Medicine. 1997;336:1066–1071
  61. Chiasson JL, Shikama H, Chu DT, et al. Inhibitory effect of epinephrine on insulin-stimulated glucose uptake by rat skeletal muscle. The Journal of Clinical Investigation. 1981;68:706–713
  62. Haring H, Kirsch D, Obermaier B, et al. Decreased tyrosine kinase activity of insulin receptor isolated from rat adipocytes rendered insulin-resistant by catecholamine treatment in vitro. Biochemical Journal. 1986;234:59–66
  63. Lang CH. Sepsis-induced insulin resistance in rats is mediated by a beta-adrenergic mechanism. American Journal of Physiology. 1992;263:E703–E711
  64. Dimitriadis G, Leighton B, Parry-Billings M, et al. Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochemical Journal. 1997;321(Pt 3):707–712
  65. Smith TR, Elmendorf JS, David TS, et al. Growth hormone-induced insulin resistance: role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4. American Journal of Physiology. 1997;272:E1071–E1079
  66. Dominici FP, Cifone D, Bartke A, et al. Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice. American Journal of Physiology. 1999;277:E447–E454
  67. Maitra SR, Wojnar MM, Lang CH. Alterations in tissue glucose uptake during the hyperglycemic and hypoglycemic phases of sepsis. Shock. 2000;13:379–385
  68. Meszaros K, Lang CH, Bagby GJ, et al. Tumor necrosis factor increases in vivo glucose utilization of macrophage-rich tissues. Biochemicl and Biophysical Research Community. 1987;149:1–6
  69. Bird TA, Davies A, Baldwin SA, et al. Interleukin 1 stimulates hexose transport in fibroblasts by increasing the expression of glucose transporters. The Journal of Biologicl Chemistry. 1990;265:13578–13583
  70. Vary TC, Drnevich D, Jurasinski C, et al. Mechanisms regulating skeletal muscle glucose metabolism in sepsis. Shock. 1995;3:403–410
  71. Wolfe RR, Jahoor F, Herndon DN, et al. Isotopic evaluation of the metabolism of pyruvate and related substrates in normal adult volunteers and severely burned children: effect of dichloroacetate and glucose infusion. Surgery. 1991;110:54–67
  72. Hotchkiss RS, Karl IE. Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. Journal of the American Medical Association. 1992;267:1503–1510
  73. Vary TC, Siegel JH, Nakatani T, et al. Regulation of glucose metabolism by altered pyruvate dehydrogenase activity. I. Potential site of insulin resistance in sepsis. JPEN Journal of Parenteral and Enteral Nutrition. 1986;10:351–355
  74. Shangraw RE, Jahoor F, Wolfe RR, et al. Pyruvate dehydrogenase inactivity is not responsible for sepsis-induced insulin resistance. Critical Care Medicine. 1996;24:566–574
  75. Saeed M, Carlson GL, Little RA, et al. Selective impairment of glucose storage in human sepsis. British Journal of Surgery. 1999;86:813–821
  76. del Aguila LF, Claffey KP, Kirwan JP. TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. American Journal of Physiology. 1999;276:E849–E855
  77. Fan J, Li YH, Wojnar MM, et al. Endotoxin-induced alterations in insulin-stimulated phosphorylation of insulin receptor, IRS-1, and MAP kinase in skeletal muscle. Shock. 1996;6:164–170
  78. Kelley DE, Mokan M, Simoneau JA, et al. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. The Journal of Clinical Investigation. 1993;92:91–98
  79. Suikkari AM, Koivisto VA, Rutanen EM, et al. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. The Journal of Clinical Endocrinology and Metabolism. 1988;66:266–272
  80. Mesotten D, Delhanty PJ, Vanderhoydonc F, et al. Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. The Journal of Clinical Endocrinology and Metabolism. 2002;87:5516–5523
  81. Wolfe RR, Burke JF. Glucose and lactate metabolism in experimental septic shock. American Journal of Physiology. 1978;235:R219–R227
  82. McCowen KC, Ling PR, Ciccarone A, et al. Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade. Critical Care Medicine. 2001;29:839–846
  83. Iynedjian PB. Mammalian glucokinase and its gene. Biochemical Journal. 1993;293(Pt 1):1–13
  84. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends in Cell Biology. 2001;11:372–377
  85. Hirosumi J, Tuncman G, Chang L, et al. A central role for JNK in obesity and insulin resistance. Nature. 2002;420:333–336
  86. Xu J, Kim HT, Ma Y, et al. Trauma and hemorrhage-induced acute hepatic insulin resistance: dominant role of tumor necrosis factor-alpha. Endocrinology. 2008;149:2369–2382
  87. Rosmarin DK, Wardlaw GM, Mirtallo J. Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose. Nutrition in Clinical Practice. 1996;11:151–156
  88. Pagliassotti MJ, Cherrington AD. Regulation of net hepatic glucose uptake in vivo. Annual Review of Physiology. 1992;54:847–860
  89. Mesotten D, Swinnen JV, Vanderhoydonc F, et al. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. The Journal of Clinical Endocrinology and Metabolism. 2004;89:219–226
  90. Mesotten D, Wouters PJ, Peeters RP, et al. Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. The Journal of Clinical Endocrinology and Metabolism. 2004;89:3105–3113
  91. Langouche L, Vander Perre S, Wouters PJ, et al. Effect of intensive insulin therapy on insulin sensitivity in the critically ill. The Journal of Clinical Endocrinology and Metabolism. 2007;92:3890–3897
  92. Vanhorebeek I, De Vos R, Mesotten D, et al. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet. 2005;365:53–59
  93. Nygren J, Thorell A, Efendic S, et al. Site of insulin resistance after surgery: the contribution of hypocaloric nutrition and bed rest. Clinical Science (London). 1997;93:137–146
  94. Soop M, Nygren J, Thorell A, et al. Preoperative oral carbohydrate treatment attenuates endogenous glucose release 3 days after surgery. Clinical Nutrition. 2004;23:733–741
  95. Van Cromphaut SJ, Vanhorebeek I, Van den Berghe G. Glucose metabolism and insulin resistance in sepsis. Current Pharmaceutical Design. 2008;14:1887–1899
  96. Langouche L, Vanhorebeek I, Vlasselaers D, et al. Intensive insulin therapy protects the endothelium of critically ill patients. The Journal of Clinical Investigation. 2005;115:2277–2286
  97. Langouche L, Meersseman W, Vander Perre S, et al. Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients. Critical Care Medicine. 2008;36:1475–1480
  98. Vanhorebeek I, Peeters RP, Vander Perre S, et al. Cortisol response to critical illness: effect of intensive insulin therapy. The Journal of Clinical Endocrinology and Metabolism. 2006;91:3803–3813

PII: S1521-6896(09)00050-0

doi: 10.1016/j.bpa.2009.08.005

Best Practice & Research Clinical Anaesthesiology
Volume 23, Issue 4 , Pages 375-386 , December 2009

Article Tools

* Image Usage & Resolution